Figure 4
Figure 4. Probability of overall survival after allogeneic HCT for therapy-related AML and MDS, by risk factors.

Probability of overall survival after allogeneic HCT for therapy-related AML and MDS, by risk factors.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal